| 标题 |
Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of the European Academy of Dermatology and Venereology : JEADV 作者:Thaçi D; Kimball A; Foley P; Poulin Y; Levi E; et al 出版日期:2017/03/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)